Causes and factors associated with early failure in hospitalized patients with community-acquired pneumonia.

Arch Intern Med

Infectious Disease Service, Hospital Universitari de Bellvitge, University of Barcelona, L'Hospitalet, Barcelona, Spain.

Published: March 2004

AI Article Synopsis

  • Early failure in treating community-acquired pneumonia occurs in about 6% of hospitalized adults, with significant causes including progressive pneumonia and pleural empyema.
  • Independent risk factors for early failure are older age, multilobar pneumonia, high Pneumonia Severity Index scores, and certain types of pneumonia, like Legionella.
  • Those who experience early failure have much higher rates of complications and mortality compared to those who respond to treatment, highlighting the importance of timely and appropriate clinical assessment and therapy.

Article Abstract

Background: Early failure is a matter of great concern in the treatment of community-acquired pneumonia. However, information on its causes and risk factors is lacking.

Methods: Observational analysis of a prospective series of 1383 nonimmunosuppressed hospitalized adults with community-acquired pneumonia. Early failure was defined as lack of response or worsening of clinical or radiologic status at 48 to 72 hours requiring changes in antibiotic therapy or invasive procedures. Concordance of antimicrobial therapy was examined for cases with an etiologic diagnosis.

Results: At 48 to 72 hours, 238 patients (18%) remained febrile, but most of them responded without further changes in antibiotic therapy. Eighty-one patients (6%) had early failure. The main causes of early failure were progressive pneumonia (n = 54), pleural empyema (n = 18), lack of response (n = 13), and uncontrolled sepsis (n = 9). Independent factors associated with early failure were older age (>65 years) (odds ratio [OR], 0.35), multilobar pneumonia (OR, 1.81), Pneumonia Severity Index score greater than 90 (OR, 2.75), Legionella pneumonia (OR, 2.71), gram-negative pneumonia (OR, 4.34), and discordant antimicrobial therapy (OR, 2.51). Compared with treatment responders, early failures had significantly higher rates of complications (58% vs 24%) and overall mortality (27% vs 4%) (P<.001 for both).

Conclusions: Early failure is infrequent but is associated with high morbidity and mortality rates. Its detection and management require careful clinical assessment. Most cases occur because of inadequate host-pathogen responses. Discordant therapy is a less frequent cause of failure, which may be preventable by rational application of the current antibiotic guidelines.

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinte.164.5.502DOI Listing

Publication Analysis

Top Keywords

early failure
24
community-acquired pneumonia
12
factors associated
8
associated early
8
pneumonia
8
lack response
8
changes antibiotic
8
antibiotic therapy
8
antimicrobial therapy
8
early
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!